Entera Bio

Entera Bio Revenue per Share

Revenue per Share of Entera Bio (ENTX) as of Nov 22, 2026.

Revenue per Share

0.00USD

YoY

-81.09%

Last updated:

Revenue per Share of Entera Bio is 2025 0.00 USD. Revenue per Share of Entera Bio was 2024 0.00 USD. It decreases by -81.09% lower compared to the previous year.

The Entera Bio Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2020
0.02 USD
Jan 1, 2021
0.02 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
Jan 1, 2026 (e)
0.00 USD
Jan 1, 2027 (e)
0.00 USD
The Entera Bio Revenue per Share history
YEARRevenue per ShareYoY
est0.00USD—
est0.00USD-100.00%
0.00USD-81.09%
0.00USD+920.10%
0.00USD-89.87%
0.00USD-76.64%
0.02USD-0.02%
0.02USD+1.63%
0.02USD-53.98%
0.04USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Entera Bio Stock analysis

What does Entera Bio do? Entera Bio Ltd is an emerging biotechnology company focused on developing oral medications to treat unmet medical needs. The company was founded in 2010 and is headquartered in Jerusalem, Israel. Its history began with the discovery of the "EnteraGam" molecule in the intestinal cells of breastfed infants, which helps them fight infections. This led to the development of EnteraGam for the treatment of various autoimmune diseases. The company's business model is based on developing oral formulations for existing drugs and discovering and developing new molecules. Its focus areas are osteoporosis, hypoparathyroidism, chronic kidney disease, and autoimmune diseases. Entera Bio is divided into three business divisions: the Oral Protein Delivery Platform, the Oral Parathyroid Hormone (PTH) Platform, and the Collagen-based Platform for Wound Healing. Its products include EB611, a candidate for hypoparathyroidism treatment, EB613 for osteoporosis treatment, and EB612 for chronic kidney disease. These products have potential to improve the lives of millions of patients worldwide. Entera Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Entera Bio stock

On Eulerpool you can find the complete historical development of Revenue per Share Entera Bio since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Entera Bio

All Key Metrics — Entera Bio